Annual Report

Aquestive Therapeutics, Inc. Filed 2024-03-05 Acc 0001628280-24-009010

Documents 1

2025-03-05 10-K Annual Report
2024-03-11 4 SVP, General Counsel acquired 135,000 shares (grant or award)
2024-03-11 4 Chief Innovation/Tech Officer acquired 82,500 shares (grant or award)
2024-03-08 144 Sale of Securities
2024-03-05 10-K Annual Report
2024-03-05 8-K Results of operations · Regulation FD disclosure
2023-03-31 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading aqst-20231231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…